Additional Notes on Clinical Repeated-Dose Pharmacokinetic Trials Applying a Peak-and-Trough Sampling Design to Estimate Oral Clearance

スポンサーリンク

概要

• 論文の詳細を見る
• 2008-04-25

著者

• Shimizu Takako

  Second Department Of Internal Medicine Graduate School Of Medicine University Of Toyama

• Shimizu T

  Department Of Pharmacy Kyoto University Hospital Faculty Of Medicine Kyoto University

• TAGUCHI Masato

  Graduate School of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University

• HASHIMOTO Yukiya

  Graduate School of Pharmaceutical Sciences, Toyama Medical and Pharmaceutical University

• Shimizu Takako

  Graduate School Of Pharmaceutical Sciences University Of Toyama

• Hashimoto Y

  Graduate School Of Pharmaceutical Sciences Kyushu University

• Kayano Yuichiro

  Graduate School Of Medicine And Pharmaceutical Sciences University Of Toyama

• Hashimoto Yuichi

  Institute Of Molecular & Cellular Biosciences University Of Tokyo

• Harada Yuichi

  Center For Influenza Virus Research National Institute Of Infectious Diseases

• Taguchi Masato

  Graduate School Of Medicine And Pharmaceutical Sciences Univ. Of Toyama

• Hashimoto Yukiya

  Graduate School Of Medicine And Pharmaceutical Sciences Univ. Of Toyama

• TAKAAI Mari

  Graduate School of Pharmaceutical Sciences, University of Toyama

• Hashimoto Y

  Institute Of Molecular & Cellular Biosciences The University Of Tokyo

• Hashimoto Yuichi

  Institute of Molecular & Cellular Biosciences, The University of Tokyo

• Takaai Mari

  Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama

関連論文

• Fluvastatin Attenuates Diabetes-Induced Cardiac Sympathetic Neuropathy in Association With a Decrease in Oxidative Stress
• Coordination of Divalent Metal Cation to Amide Group to Form Adduct Ion in FAB Mass Spectrometry: Implication of Zn^ in Enzymatic Hydrolysis of Amide Bond
• Thermostability of Doubly Glycosylated Recombinant Lysozyme
• Expression and Characterization of Human Rheumatoid Factor Single-Chain FV
• Construction of the Single-Chain Fv from 196-14 Antibody toward Ovarian Cancer-Associated Antigen CA125
• Influence of Mutations of the N-Cap Residue, Gly4, on Stability and Structure of Hen Lysozyme
• Analysis of the Stabilization of Hen Lysozyme by Helix Macrodipole and Charged Side Chain Interaction
• Stabilization of Lysozyme by Introducing N-Glycosylation Signal Sequence
• A Mutation Study of Catalytic Residue Asp 52 in Hen Egg Lysozyme^1
• Correlation between the Differences in the Free Energy Change and conformational Energy in the Folded State of Hen Lysozymes with Gly-Pro and Pro-Gly Sequences Introduced to the Same Site
• Effect of Salt Concentration on the pK_a of Acidic Residues in Lysozyme
• EFFECT OF CYP2C POLYMORPHISMS ON THE PHARMACOKINETICS OF PHENYTOIN IN JAPANESE PATIENTS WITH EPILEPSY
• Population Pharmacokinetics of Phenytoin in Japanese Patients with Epilepsy : Analysis with a Dose-Dependent Clearance Model
• PJ-373 Non-invasive Evaluation of Coronary Plaque by 64-Slice Multi-Detector Computed Tomography : Comparison with Intravascular Ultrasound Derived Virtual Histology(CT/DSA-6 (I) PJ63,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meetin
• Evaluation of Phenytoin Dosage Regimens Based on Genotyping of CYP2C Subfamily in Routinely Treated Japanese Patients
• Enhancing Effect of Tumor Promoters, Phorbol Esters and Teleocidins on Nuclear Receptor-Mediated Transcription
• Identification of Protein Disulfide Isomerase as a Phorbol Ester-Binding Protein
• α-Glucosidase Inhibitors with a 4, 5, 6, 7-Tetrachlorophthalimide Skeleton Pendanted with a Cycloalkyl or Dicarba-closo-dodecaborane Group
• α-Glucosidase Inhibitors with a Phthalimide Skeleton : Stucture-Activity Relationship Study
• Modulators of Tumor Necrosis Factor α Production Bearing Dicarba-closo-dodecaborane as a Hydrophobic Pharmacophore
• Inhibitory and Stimulative Effects of Amiodarone on Metabolism of Carvedilol in Human Liver Microsomes
• Involvement of the CYP1A Subfamily in Stereoselective Metabolism of Carvedilol in β-Naphthoflavone-Treated Caco-2 Cells(Biopharmacy)
• Novel Retinoidal Tropolone Derivatives. Bioisosteric Relationship of Tropolone Ring with Benzoic Acid Moiety in Retinoid Structure
• Retinoidal Pyrimidinecarboxylic Acids. Unexpected Diaza-Substituent Effects in Retinobenzoic Acids
• Retinoid X Receptor-Antagonistic Diazepinylbenzoic Acids
• NOVEL THIAZOLIDINEDIONE DERIVATIVES WITH RETINOID SYNERGISTIC ACTIVITY
• POTENT RETINOID SYNERGISTS WITH A DIPHENYLAMINE SKELETON
• Polyenylidine Thiazolidine Derivatives with Retinoidal Activities
• Nonlinear Mixed Effects Model Analysis of the Pharmacokinetics of Metoprolol in Routinely Treated Japanese Patients(Biopharmacy)
• PJ-794 Waon Therapy Improves Exercise Tolerance Primarily through Improvement of Endothelial Function in Patients with Heart Failure(PJ133,Heart Failure (Treatment) 4 (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circula
• PJ-110 The Effect of Combined Use of Angiotensin Receptor Blocker with Statin on Coronary Plaque Composition(PJ019,Atherosclerosis (Clinical/Treatment) 1 (IHD),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Societ
• Design and Synthesis of Phthalimide-Based Fluorescent Liver X Receptor Antagonists
• Structural Development of Benzhydrol-Type 1'-Acetoxychavicol Acetate (ACA) Analogs as Human Leukemia Cell-Growth Inhibitors Based on Quantitative Structure-Activity Relationship (QSAR) Analysis
• Structure-Based Design and Synthesis of Fluorescent PPARα/δ Co-agonist and Its Application as a Probe for Fluorescent Polarization Assay of PPARδ Ligands
• Fusarielin A as an Anti-angiogenic and Anti-proliferative Agent : Basic Biological Characterization
• Structural Development of Liver X Receptor (LXR) Antagonists Derived from Thalidomide-Related Glucosidase Inhibitors
• Development of Tubulin-Polymerization Inhibitors Based on the Thalidomide Skeleton
• Hydrolyzed Metabolites of Thalidomide : Synthesis and TNF-α Production-Inhibitory Activity
• Mono- and Dihydroxylated Metabolites of Thalidomide : Synthesis and TNF-α Production-Inhibitory Activity
• Effects of Immunomodulatory Derivatives of Thalidomide (IMiDs) and Their Analogs on Cell-Differentiation, Cyclooxygenase Activity and Angiogenesis
• Enhancement of All-trans Retinoic Acid-Induced HL-60 Cell Differentiation by Thalidomide and Its Metabolites(Communication to the Editor)
• N-Phenylphthalimide-Type Cyclooxygenase (COX) Inhibitors Derived from Thalidomide : Substituent Effects on Subtype Selectivity
• Thalidomide as a Nitric Oxide Synthase Inhibitor and Its Structural Development
• Conversion of Ca^ Salt of an Organic Compound to Its Li^+ Salt to Simplify the Fast Atom Bombardment Mass Spectrum
• Coordination of Sodium Cation to an Oxygen Function and Olefinic Double Bond to Form Molecular Adduct Ion in Fast Atom Bombardment Mass Spectrometry
• Separation of Phosphatidylinositol 4-Phosphate from a Mixture with Phosphatidylserine and Phosphatidylinositol by Sep-Pak C_ Cartridge
• Potent Homophthalimide-Type Inhibitors of B16F10/L5 Mouse Melanoma Cell Invasion
• Pharmacokinetic Characterization of Transcellular Transport and Drug Interaction of Digoxin in Caco-2 Cell Monolayers(Biopharmacy)
• PJ-450 Impaired Renal Function is Associated with Blunted Heart Rate Recovery Immediately after Exercise(PJ076,Exercise Test/Cardiac Rehabilitation 1 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)
• PJ-543 Focal Myocardial Perfusion Defects Suggest More Advanced Heart Failure in Patients with Dilated Cardiomyopathy(Nuclear cardiology(09)(I),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• FRS-014 Fluvastatin Restores Impaired Cardiac Sympathetic Neuronal Function through Reduction in Oxidative Stress in Diabetic Rats(Topics in Nuclear Cardiology(I),Featured Research Session,The 72nd Annual Scientific Meeting of the Japanese Circulation Soc
• PJ-546 Coupling between Vagal Reactivation after Exercise and Cardiac MIBG Findings in Patients with Heart Failure(Nuclear cardiology-6, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-126 Ischemic Preconditioning-Induced Acceleration of Fatty Acid Oxidation might Result from its Cardioprotective Effect : Influences of Fatty Acid Oxidation Inhibitor(Myocardial ischemia/reperfusion, basic/clinical-3, The 71st Annual Scientific Meeting
• Influence of β-Adrenoceptor Blockade on the Myocardial Accumulation of Fatty Acid Tracer and Its Intracellular Metabolism in the Heart After Ischemia-Reperfusion Injury
• PJ-780 Hyperglycemia at Reperfusion Dose Not Exacerbate Myocardial Ischemia-reperfusion Injury(Myocardial ischemia-reperfusion, basic/clinical-6 (IHD) PJ136,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulati
• PJ-728 A Combined Therapy of AT_1-receptor Antagonist may Enhance the Plaque-stabilizing Effect of Statin(Atherosclerosis, clinical-15 (H) PJ123,Poster Session (Japanese),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-726 Increase in C-Reactive Protein within Coronary Circulation after Stent Implantation Correlate with Plaque Progression at Non-Culprit Lesion : Effect of Fluvastatin(Atherosclerosis, clinical-15 (H) PJ123,Poster Session (Japanese),The 70th Anniversar
• PE-495 Increase in Necrotic Core Determined by Intravascular Ultrasound Tissue Characterization (Virtual Histology) with the Existence of High-echogenic Material(Intravascular endoscopy/Intravascular ultrasound-3 (I) PE83,Poster Session (English),The 70th
• OJ-003 Influences of CYP2D6 Genotype on Plasma Concentrations of Carvedilol : a Comparison with Metoprolol and Bisoprolol(Cardiovascular pharmacology, basic/clinical-2 (H) OJ1,Oral Presentation (Japanese),The 70th Anniversary Annual Scientific Meeting of
• FRS-036 Beneficial Effects of Ischemic Preconditioning and Diabetes on Myocardial Fatty Acid Metabolism after Ischemia-reperfusion(Advances in Nuclear Cardiology-2 (I) FRS8,Featured Research Session,The 70th Anniversary Annual Scientific Meeting of the Ja
• Nonlinear Mixed Effects Model Analysis of the Pharmacokinetics of Routinely Administered Bepridil in Japanese Patients with Arrhythmias(Biopharmacy)
• Analysis of CYP2D6 Genotype in Relation to Bepridil Pharmacokinetics in Patients with Persistent Atrial Fibrillation(Arrhythmia, Pharmacological Therapy 2 (A), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Pharmacokinetic Variability of Routinely Administered Bisoprolol in Middle-Aged and Elderly Japanese Patients(Biopharmacy)
• The Genotype of CYP2D6 Determines Cardiac Responsiveness to β-adrenergic Stimulation in patients Treated with Metoprolol, but not with Bisoprolol(Cardiovascular Pharmacology, Basic/Clinical 2 (H), The 69th Annual Scientific Meeting of the Japanese Circula
• Pharmacokinetics of R- and S-Carvedilol in Routinely Treated Japanese Patients with Heart Failure(Biopharmacy)
• PJ-337 Serial Vascular Remodeling and Regression of Coronary Plaque Components during Statin Treatment(Intravascular endoscopy/Intravascular ultrasound(06)(I),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-329 Exaggerated and sustained adrenergic responses to transient stress in heart and kidney of unanesthetized hypertensive rats(Hypertension, basic(03)(H),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• PJ-072 A combination of assessment of carotid artery plaque with matrix metalloproteinase-9 may predict coronary vulunerable plaque(CT/DSA(07)(I),Poster Session(Japanese),The 72nd Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-063 CYP2D6 Genotype Has little Influences on Plasma Concentrations of Carvediol : A Comparison with Metoprolol and Bisoprolol.(Cardiovascular pharmacology, basic/clinical(02)(H),Oral Presentation(Japanese),The 72nd Annual Scientific Meeting of the Japa
• Collisionally Activated Dissociation of 13-Membered Peptides, Ustiloxins, and Phomopsins
• Effect of CYP2D6^*10 on the Pharmacokinetics of R- and S-Carvedilol in Healthy Japanese Volunteers(Biopharmacy)
• Characterization of Poly-Leucine Substituted Analogues of the Human Surfactant Protein SP-C
• The Surface Properties of Chemically Synthesized Peptides Analogous to Human Pulmonary Surfactant Protein SP-C
• Synthesis and Anti-tubulin Activity of Ustiloxin D Derivatives
• Isolation and Structure of an Antimitotic Cyclic Peptide, Ustiloxin F: Chemical Interrelation with a Homologous Peptide, Ustiloxin B
• Development of Novel Chiral Urea Catalysts for the Hetero-Michael Reaction
• Population Pharmacokinetics of Higher-Dose Mizoribine in Healthy Male Volunteers(Biopharmacy)
• Hepatic Extraction of Tacrolimus in Rats with Experimental Liver Diseases
• Intestinal Expression and Metabolic Activity of the CYP3A Subfamily in Female Rats(Biopharmacy)
• Nonlinear Mixed Effects Model Analysis of the Pharmacokinetics of Aripiprazole in Healthy Japanese Males(Biopharmacy)
• Membrane Transport Mechanisms of Mizoribine in the Rat Intestine and Human Epithelial LS180 Cells(Biopharmacy)
• The Apical Uptake Transporter of Levofloxacin is Distinct from the Peptide Transporter in Human Intestinal Epithelial Caco-2 Cells
• Directional Transcellular Transport of Bisoprolol in P-glycoprotein-expressed LLC-GA5-COL150 Cells, but not in Renal Epithelial LLC-PK_1 Cells
• Stereoselective Oxidation and Glucuronidation of Carvedilol in Human Liver and Intestinal Microsomes(Biopharmacy)
• Additional Notes on Clinical Repeated-Dose Pharmacokinetic Trials Applying a Peak-and-Trough Sampling Design to Estimate Oral Clearance
• Population Pharmacokinetics and Proton Pump Inhibitory Effects of Intravenous Lansoprazole in Healthy Japanese Males(Analytical Biochemistry)
• Pharmacokinetic Analysis of Transcellular Transport of Levofloxacin across LLC-PK_1 and Caco-2 Cell Monolayers(Biopharmacy)
• Simulation for Clinical Repeated-Dose Pharmacokinetic Trials Applying a Peak-and-Trough Sampling Design to Estimate Oral Clearance(Biopharmacy)
• UGT2B7^*3はR-, S-カルベジロールの体内動態に影響を及ぼさない
• LS180細胞におけるVDRリガンドのCYP3A4発現誘導活性の評価
• Stereoselective Metabolism of Carvedilol by the β-Naphthoflavone-Inducible Enzyme in Human Intestinal Epithelial Caco-2 Cells(Biopharmacy)
• Pharmacokinetics and Hepatic Extraction of Metoprolol in Rats with Glycerol-Induced Acute Renal Failure(Biopharmacy)
• 尿管結紮腎不全モデルラットにおけるビソプロロールの体内動態と薬効の解析
• Endogenous Uremic Substances are not Involved in the Reduced Hepatic Extraction of Metoprolol in Bilateral Ureter-Ligated Rats
• Multiple Regression Analysis of Pharmacogenetic Variability of Carvedilol Disposition in 54 Healthy Japanese Volunteers(Biopharmacy)
• Pharmacokinetic Analysis of Transcellular Transport of Quinidine across Monolayers of Human Intestinal Epithelial Caco-2 Cells(Biopharmacy)
• OJ-326 The Genotype of CYP2D6 Determines the Cardiovascular Responsiveness to Isoproterenol in Patients Treated with Metoprolol(Cardiovascular Pharmacology, Basic/Clinical 2 (H) : OJ39)(Oral Presentation (Japanese))
• Intestinal Absorption and Hepatic Extraction of Propranolol and Metoprolol in Rats with Bilateral Ureteral Ligation(Biopharmacy)
• A Simulation Study to Evaluate Limited Sampling Strategies to Estimate Area under the Curve of Drug Concentration versus Time Following Repetitive Oral Dosing: Limited Sampling Model versus Naive Trapezoidal Method
• Impact of myocardial perfusion abnormality on prognosis in patients with non-ischemic dilated cardiomyopathy

もっと見る 閉じる

スポンサーリンク